Candesartan Fails to Alter Tau Pathology in Transgenic Mouse Model
A preclinical study found that six weeks of candesartan administration did not modify tau pathology, receptor levels, or neuroinflammatory markers ...
A preclinical study found that six weeks of candesartan administration did not modify tau pathology, receptor levels, or neuroinflammatory markers ...
A new review argues that acetylcholinesterase acts beyond breaking down acetylcholine, accelerating amyloid-beta aggregation and tau pathology while remaining a ...
A new review proposes matching lipid nanoparticle designs to specific Alzheimer's disease pathways, from neuronal BACE1 siRNA delivery to microglia-targeted ...
A new review proposes that histone post-translational modifications sustain neuroinflammation in Alzheimer's disease by encoding pathological immune memory in chromatin.
A two-cohort study finds that CSF synaptic biomarkers rise with tau pathology but stay near baseline when amyloid plaques appear ...
A review integrates associative observations in patients with Alzheimer's disease and mild cognitive impairment alongside experimental and animal findings on ...
A new review finds that psychobiotics and fermented foods show neuroprotective effects in animal models of Alzheimer's disease, while clinical ...
Brief antibody-mediated depletion of CD8+ T cells in aged APP/PS1 mice left amyloid plaques unchanged but reduced dystrophic neurites and ...
A new study links upregulated Src kinase and the transcription factor NEUROD2 to early tau pathology in Alzheimer's disease, supported ...
A controlled study of mice with tau pathology found that BCG vaccination reduced brain inflammation and tau deposition and improved ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine